Abortion Pill Reversal

West Virginia House approves bill requiring women to be told about abortion pill reversal

abortion pill, virginia

The Second Chance at Life Act, or House Bill 2982, passed by a vote of 83-15 in the West Virginia House of Delegates on Wednesday, March 24, with seven Democrats joining the Republican majority. The bill now heads to the state Senate for a vote.

If passed into law, the Act would require mothers obtaining the abortion pill to be informed of Abortion Pill Reversal at that time. The abortion pill regimen consists of two drugs: mifepristone and misoprostol. The first blocks progesterone, which  essentially starves the preborn child of nutrients, leading to his or her death. The second drug causes the mother to deliver her dead child, causing extreme cramping and bleeding. Since the abortion pill was FDA-approved in the United States in 2000, nearly four million children have been killed with the drug and at least 24 mothers have died after taking it.

Abortion Pill Reversal is a progesterone regimen that has the potential to counter the devastating effects of mifepristone (a progesterone inhibitor) and save the child’s life. Many mothers have successfully reversed their abortions and saved their children’s lives with Abortion Pill Reversal. Progesterone has long been dispensed to women at risk of miscarriage, yet the abortion industry and its allies have attempted to smear the reversal protocol as “junk science.” 

READ: Media puts biased ‘disclaimer’ on OB/GYN’s abortion pill reversal op-ed

House Bill 2982 mandates that women seeking the abortion pill are to be informed, “If you change your mind, it may be possible to avoid, cease, or even to stop the intended effects of a chemical abortion utilizing mifepristone, if the second pill has not been taken. Please consult with a health care provider.” The bill would also require that the state’s Department of Health and Human Resources create physical handouts to provide women considering the abortion pill with information on Abortion Pill Reversal.

Republican House member Tom Fast said of the Second Chance at Life Act, “It speaks to the other person in the equation. In these situations, let’s not forget there are two people. You have the mother, and you have the unborn child. Telling the mother … if you change your mind, it may be possible to reverse this first medication. I think that is the cap on informed consent.”

Editor’s Note 4/16/21: “The FDA has received reports of serious adverse events in women who took Mifeprex. As of December 31, 2018, there were reports of 24 deaths of women associated with Mifeprex since the product was approved in September 2000, including two cases of ectopic pregnancy resulting in death; and several cases of severe systemic infection (also called sepsis), including some that were fatal.

The adverse events cannot with certainty be causally attributed to mifepristone because of concurrent use of other drugs, other medical or surgical treatments, co-existing medical conditions, and information gaps about patient health status and clinical management of the patient. A summary report of adverse events that reflects data through December 31, 2018 is here.” https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/questions-and-answers-mifeprex

“Like” Live Action News on Facebook for more pro-life news and commentary!

What is Live Action News?

Live Action News is pro-life news and commentary from a pro-life perspective. Learn More

Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.

GUEST ARTICLES: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated. (See here for Open License Agreement.) Thank you for your interest in Live Action News!

To Top